Everything You Need To Know About Remdesivir, The Potential COVID-19 TreatmentResults of the coronavirus trial — which was sponsored by the National Institute of Allergy and Infectious Diseases — found that recovery time for patients who took remdesivir was 11 days, as compared to 15 days for patients in the control group — a 31% faster time to recovery.2
Uncovering the tricks of game changer antibiotic teixobactinUtrecht scientists have discovered how the powerful antibiotic teixobactin kills bacteria. Heralded as a breakthrough drug, the discovery of teixobactin marked a milestone for combating drug-resistant superbugs. However, the way teixobactin binds to its target was hitherto unknown. An international group, led by Dr. Markus Weingarth of Utrecht University, presents the structure of teixobactin 5 June in Nature Communications.
Man Battling Cancer Wins $200,000 Lottery Prize On Last Day Of ChemotherapyRonnie Foster was already on top of the world as he headed to his final round of chemotherapy – then he won the lottery. Foster, from Pink Hill, North Carolina, is battling colon cancer. As he made his way to the hospital for his last chemotherapy treatment, he was already having a great day. According …7
Depression and Complementary Health ApproachesMany individuals with depression turn to complementary health approaches as an adjunct to or in place of conventional treatment. Although these approaches are commonly used and readily available in the marketplace, many of them have not been rigorously studied for the treatment of depression.
Experimental Anti-Aging Treatment Still Has Few Kinks, Report Infant ResearchersBOSTON—Calling it a minor setback for what otherwise appeared to be a promising new medical intervention, a team of infant researchers announced Wednesday that their experimental anti-aging treatment still has a few kinks. “Though broadly successful across several different metrics, there were a few unforeseen, but relatively minor, complications in our initial trials that we are currently working to address,” said lead researcher Dr. Leonard Rothman, spittle dribbling down his pudgy cheek as he struggled to peek his little, bald head above the podium. “We have achieved tremendous results over the course of our tests, and although we’ve run into a few hitches along the way, we are confident that this will be a viable treatment.” Dr. Rothman added that his team very much looked forward to completing their work when their bodies were once again developed enough to operate lab equipment.